ASGCT Annual Meetings 2022-24: Travel Awards and Underrepresented Minority Travel Awards

2022-24 年 ASGCT 年会：旅行奖和代表性不足的少数族裔旅行奖

• 批准号: 10469145
• 负责人: David Barrett
• 金额: $ 1.5万
• 依托单位: AMERICAN SOCIETY OF GENE & CELL THERAPY
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-05-01 至 2025-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10469145
• 关键词: American; Award; Awareness; Cell Therapy; Chronic Disease; Clinical Trials; Databases; Development; Disease; Education; Event; Funding; Future; Goals; Grant; Improve Access; Individual; Industry; Knowledge; Learning; Mission; Outcome; Population; Positioning Attribute; Postdoctoral Fellow; Public Health; Rare Diseases; Reporting; Research; Research Personnel; Running; Societies; Students; Travel; Underrepresented Minority; Underrepresented Populations; United States National Institutes of Health; career; career networking; clinical application; clinical development; cost; diversity and inclusion; experience; gene therapy; human disease; meeting abstracts; meetings; member; product development; research and development; success

American Society of Gene and Cell Therapy PA-21-151 PROJECT SUMMARY This application by The American Society of Gene and Cell Therapy (ASGCT) requests $15,000 for 10 travels award and 20 underrepresented minority travel awards ($500 per award) for students and post-doctoral fellows to attend the ASGCT Annual Meetings in 2022, 2023, and 2024—for a total of $45,000 and 90 travel awards. To determine awards, ASGCT run a report from our abstract presenter database that pools abstract applicants who are students or post-doctoral fellows. Those with the top 15 scoring abstracts receive an Excellence in Research Award (not supported by this grant), and those scoring over 3.5 receive a $500 travel award (such as those supported by this grant). Then, remaining applicants who identify as underrepresented individuals are ranked by score, and the top 20 are given travel awards (also to be supported by this grant). ASGCT abides strictly by the NIH’s definition of underrepresentation populations in selecting awardees. ASGCT’s mission is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. This project bolsters our mission by supporting early-career professional to travel to our Annual Meetings to gain exposure for their research, thereby advancing knowledge and spurning professional development that will better position those early-career professionals to make discoveries and produce clinical applications in the future.

美国基因与细胞治疗学会 PA-21-151 项目摘要 美国基因和细胞治疗学会（ASGCT）的这份申请要求15,000美元， 为学生提供10个旅行奖和20个代表性不足的少数民族旅行奖（每个奖500美元）， 博士后研究员参加2022年，2023年和2024年的ASGCT年会-共计 45 000美元和90份旅行奖励。为了确定奖项，ASGCT运行一个报告，从我们的摘要 演讲者数据库，汇集了学生或博士后研究员的抽象申请人。那些 与前15名得分摘要获得卓越研究奖（不支持本 奖金），而那些得分超过3.5的人将获得500美元的旅行奖励（例如那些获得 grant）。然后，剩余的申请人谁确定为代表性不足的个人排名的分数， 前20名获得旅行奖励（也由该赠款支持）。ASGCT严格遵守 美国国立卫生研究院在选择获奖者时对代表性不足人群的定义。 ASGCT的使命是促进知识，意识和教育，从而发现和 基因和细胞疗法在缓解人类疾病方面的临床应用。该项目支持 我们的使命是支持职业生涯初期的专业人士参加我们的年会， 暴露他们的研究，从而提高知识和唾弃专业发展 这将更好地帮助那些早期职业专业人士做出发现并产生临床成果 应用程序。